Reach Diagnostic
Wuhan, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A leading Chinese POCT diagnostics manufacturer specializing in rapid test kits for infectious diseases, cardiac markers, and food safety using colloidal gold and fluorescence technologies.
Infectious DiseaseCardiologyEndocrinologyGastroenterology
Technology Platform
Multiple diagnostic platforms including colloidal gold immunochromatography for rapid tests, fluorescence immunoassay, ELISA, chemiluminescence, and PCR-based detection methods.
Opportunities
Growth opportunities include expanding global distribution of their comprehensive diagnostic portfolio, leveraging their integrated manufacturing for cost-competitive OEM services, and developing tests for emerging infectious diseases and food safety concerns.
Risk Factors
Key risks include intense competition in the Chinese IVD market, regulatory challenges in international markets, potential supply chain disruptions for raw materials, and dependence on infectious disease testing demand which can be cyclical.
Competitive Landscape
Competes with Chinese IVD companies like BioSino, Wantai, and multinational corporations; differentiates through vertical integration, flexible OEM policies, and comprehensive product portfolio across multiple diagnostic technologies.